Brexit and Healthcare Industry – Implications for Pharma – Q3 2019
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
It has been over three years since the UK voted to leave the EU. After the UK and the EU agreed to a third delay to Brexit, it is now due to happen on 31 January, 2020 and negotiations are still ongoing to determine the UK’s relationship with the EU after Brexit.
This report provides an assessment of how the pharmaceutical industry expects Brexit to affect the healthcare sector, both within and outside of Britain. This study will be repeated in H1 2020, to gauge the changing sentiment towards Brexit from within the healthcare industry.
Scope
GlobalData’s Brexit and the Healthcare Industry – Implications for Pharma, Q3 2019 provides in-house analyst expertise on the results of a 10 minutes survey of 80 GlobalData Pharma clients and prospects which was fielded from November 12, 2019 to November 28, 2019. This report includes and is based around industry opinions after the third extension of the Brexit deadline and announcement of the UK’s general election.
Components of the report include:
Outcomes of Brexit – Brexit outcome on Januray 31 2020, best and most likely outcomes of Brexit providing respondent mix by geography
Factors to Impact Healthcare—key factors to impact the post-Brexit UK healthcare industry providing respondent mix by region and seniority level as compared to previous survey waves in 2018 and 2019
Impact on Research and Manufacturing — key factors to impact healthcare research and manufacturing in the UK post-Brexit providing respondent mix by region and seniority level as compared to previous survey waves in 2018 and 2019
Impact on Corporate Strategy —level of impact of Brexit on corporate strategy providing respondent mix by region, seniority level, and headquarter location as compared to to previous survey waves in 2018 and 2019
Impact on Relocation — impact of Brexit on staff and headquarter relocation as indicated by resondents whose headquarters is located in the UK as compared to to previous survey waves in 2018 and 2019
Reasons to Buy
Develop and design your corporate strategies post-Brexit through an in-house expert analysis of the key factors to impact the post-Brexit UK healthcare industry.
Develop business strategies by understanding the key factors to impact healthcare research and manufacturing in the UK post-Brexit.
Stay up to date on the industry’s changing sentiment towards Brexit from within the healthcare industry.
Identify emerging industry trends post-Brexit to gain a competitive advantage.
Table of Contents
Frequently asked questions
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.